ClinicalTrials.gov
ClinicalTrials.gov Menu

Molecular Screening for Cancer Treatment Optimization (MOSCATO 02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01566019
Recruitment Status : Recruiting
First Posted : March 29, 2012
Last Update Posted : July 12, 2016
Sponsor:
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris